comprehensive -WSS

comprehensive

author：fashion 2025-10-03 01:02:52 - browse：13421

Richard Neal(D-MA), Rep. Frank Pallone (D-NJ),Rep. John Yarmuth (D-KY), Rep. Bobby Scott (D-VA) and House Minority Leader Nancy Pelosi (D-CA) attend the weekly press conference in the Capitol building on July 20, 2017 in Washington, DC. They spoke to the media about the efforts to reform the health care bill. -- health policy coverage from STAT — Reps. Richard Neal (D-Mass.), Rep. Frank Pallone (D-N.J.), and Rep. John Yarmuth (D-Ky.) Joe Raedle/Getty Images

WASHINGTON — It’s drug pricing déjà vu: Just as they did in 2019, House Democrats are pushing a bill that would allow Medicare to negotiate dozens of drug prices a year, offer those prices to all insurers, and crack down on price hikes.

Unlike then, Democrats have a starting place: the new bill represents an expansion of the major drug pricing legislation the party passed last year. But the first round of drug price negotiations hasn’t even started yet, and the law is under attack from the pharmaceutical industry in court.

The Democratic leaders of three key House committees put forth the proposal Wednesday.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： How to fix cancer clinical trials' diversity problem

focus

WSS

Weighted lottery helped low

Why Novartis is changing the name of its research labs

Amazon on where the company's health care bets are headed next

Abortion pill Supreme Court ruling could impact entire drug industry

FDA's naming rule on biosimilars has undermined competition

House transparency, PBM reform bill gains bipartisan support

knowledge

comprehensive

focus

Medical records are filled with copy

Merck drug for rare lung condition set for approval in U.S.

Hepatitis C has a cure — but many Americans still lack access to it

Study says nonprofit hospitals fall short in charity care spending

Supreme Court strikes down use of affirmative action

How to fix cancer clinical trials' diversity problem

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Psychedelics group wrestles with new pharma identity

ALS advocates say criticism of new drugs misses bigger picture

knowledge

House transparency, PBM reform bill gains bipartisan support

Primary care physicians play key roles in Alzheimer's management

Humana sues Biden admin over Medicare Advantage audit rule

Trump surgeon general acknowledges mistakes during Covid

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Eliminate the waiting period for sterilization covered by Medicaid

Wikipedia

focus

focus

entertainment